Pharmacology: defining the optimal dose of a new drug: a crucial decision.
Heerspink
Hiddo Lambers
HL
de Zeeuw
Dick
D
D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000517:prevention & control*; D012084:Renin-Angiotensin System / Q000187:drug effects*
D047228:Angiotensin II Type 1 Receptor Blockers
J Cardiovasc Pharmacol. 2003 Dec;42(6):752-6
14639097
Drugs. 1980 Dec;20(6):409-52
7009133
J Am Soc Nephrol. 2009 Apr;20(4):688-9
19279124
J Am Soc Nephrol. 2009 Mar;20(3):655-64
19144760
Kidney Int. 2004 Jun;65(6):2309-20
15149345
Diabetes. 1998 Mar;47(3):450-6
9519753